Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just watched GDR Investor Meet Co (IMC)presentation. Funding needed. . 25% drop in SP in an hour. This would harm AS more than any other platform. Direct questions to not deflect with China. Another Lung Cancer detection Co LLAI is on IMC platform this afternoon at 4pm, free to use. They are using AI to help screen lung nodules that may not be cancerous. Some early data suggest 81% success. We need a test out this year. Or 1p will be the best we can hope for. It is all due to lack of trust. Very near term AS. In US Bill we hope for delivery of funds.
Attractive SP for newbies imo
Hopefully within 30 days the $100000 will come in , more importantly that would indicate positive vibes from the US HNWI
From last interview it appears AS has finally got the message about keeping share holders in the loop ..
Plenty of opportunity for positive momentum now
We should see an increased amount of interest given placees will receive their shares and want to promote it
The narrative now is that the communication from the company is deplorable
When someone has pumped the share for 6 months (they know a lot about Ciz), then flips narrative, just game playing…
At least with someone like Chris H, he took grief for pumping it and selling but has been straight, came back in again when thought it was undervalued…
I'm sure you'd rather have to go licensing out instead of having 9 figure operating costs...
Just a wider bit of lung cancer news re treatment for anyone interested…
Britain’s biggest drugmaker AstraZeneca has received a boost, as its blockbuster cancer drug Imfinzi showed positive results as a treatment for aggressive lung cancer in a late-stage clinical trial.
The drug demonstrated a “statistically significant and clinically meaningful improvement” in both the overall survival of patients with limited-stage small cell lung cancer, and the survival of of patients without the disease progressing.
Small cell lung cancer is a highly aggressive form of cancer that typically recurs and progresses rapidly despite initial response to chemotherapy and radiotherapy, with only 15%-30% of these patients alive five years after diagnosis, AstraZeneca said.
Susan Galbraith, executive vice president of oncology research & development at the drugmaker, said:
These exciting results build on the transformative efficacy of Imfinzi in extensive-stage small cell lung cancer and demonstrate the potential to bring a curative-intent immunotherapy treatment to this earlier-stage setting of small cell lung cancer for the first time.
These data, together with the PACIFIC data in unresectable, Stage III non-small cell lung cancer, underscore the pioneering role of Imfinzi in the treatment of early lung cancer following chemoradiotherapy.
After ramping up research spending and through a series of smart bets, AstraZeneca has built up a portfolio of cancer drugs that accounts for almost a quarter of the company’s annual revenues.
Here they come.
Hold on to your shares.
Doesn’t sound like a good deal to me.
In fact it’s a terrible one
More opportunities elsewhere
Oh , I agree they've been misleading. Don't get me wrong I am miffed. I've lost money on a falsely reported agenda. I've got a third of holdings left.
But, lets see if they show more veracity from now on. One more BS event and I'll be out.
It’s not how many I sold Tech. It’s that I believed the previous RNS releases suggesting that the “ next steps are to finalise standard production and operating protocols and to commence clinical trials that should lead to an accredited Laboratory Developed (LDT) test for launch initially in the USA” When clearly they’ve been spinning plates
Nope, I agree, I've no idea how many you sold OAPK, but you did keep referencing it (derisking). . So therefore its fair game to mention..
And since you have become more vociferous since, then it's a fair assumption that the two are linked.
Cause and effect whichever way it is
You’ve no idea how many I sold or still hold Tech.
I might be “bloody minded” but I’m not trying to defend the indefensible nor am I making deliberately overly positive assumptions about what the placing funds will or will not be spent on, which could mislead.
Oops , ignore last paragraph artefact
I do try to be fair; there is no such thing as a neutral stance in life though.
And the same way that I sometimes think that Neil probably engages in some subconscious confirmation and Jace definitely got carried away with potential...
I also think that now you've sold many, you're taking an opposite stance to be bloody minded (I know you can be a tad anyway ;o) that's OK with me)
But..your question..
"What’s that got to do with signing an agreement for 15% Royalties with CorePath and now 10% with BIO. A company set up by Mr Behnke in February this year" ?
C'mon OAPk, as Neil said, there's more companies now under one umbrella.. it's more streamlined but there's a cost for that streamlining.
The other stuff about unprofessional directors talk and fundraise... Well I can't argue with that the fundraise was inopportune. It's hard to know the reasons behind canceling the previous funding deal.
And those " interviews" on stockbox and directors talk, etc all..
None of them involving any company or what I would call interrogative challenging interviews
They're all just a PR exercise to an extent
at’s that got to do with signing an agreement for 15% Royalties with CorePath and now 10% with BIO. A company set up by Mr Behnke in February this year ?
RE "Neil, why was BIO needed...."
Dead simple - in the same way that my customers structure a deal with my company. They don't want the hassle of going to supplier A for this part, supplier B for this part, supplier C for the design, supplier D for testing.
What’s that got to do with signing an agreement for 15% Royalties with CorePath and now 10% with BIO. A company set up by Mr Behnke in February this year ?
Do you think if E3 Fund were happy to provide the £500k drawdown there would have been a placing? Do you think the interview posted 16 minutes after the release of the Placing RNS was the behaviour of a Professional and reputable company? Do you think the interview was Professional ? Do you think the interviewer was professional in their preparation and questions they asked?
Is that the sort of way you would conduct yourself in your business ?
Evening Techtonic.
The reference to AXBD was a response to Bufflehead's earlier post.
Oakp20
Can you explain how i can possibly be pumping a share when i have repeatedly said i am here long term and not interested
in the day to day share price?
In the same spirit as your request to Techtonic to provide a link, can you also provide the link to support your claim that "amateur placing forced on them because the agreed finance with e3 fund wasn't forthcoming!?
Re the placing: we will know for sure in 7 days if the placing completed. On that basis, can you tell us where YOU think the funds will be used?
Re the company being Bill Benke's house, so what? Look at Companies House to see how many companies registered office is a private residence, or a single office in a complex, or even just a PO box. It is simply a requirement where legal documents can be served.
Re the HNW's: Do you not believe the bod have performed their due diligence into whether they are legit?
Allan's comment -"absolutely delighted to have FINALLY got this agreement together, something we have been negotiating for a while"
RE "Neil, why was BIO needed...."
Dead simple - in the same way that my customers structure a deal with my company. They don't want the hassle of going to supplier A for this part, supplier B for this part, supplier C for the design, supplier D for testing.
In return for me bringing all these steps in-house, and them being provided with a "one stop shop" i am rewarded with bigger orders .
In CIZ's case, they have amalgamated these steps into one company.
We get a smaller royalty percentage initially, but are rewarded by the sales these combined partners will generate.
This is enhanced by a free holding in BIO company and a share in their profits.
Hope this helps
Neil
I don’t think I missed the AGM notice, but I am guessing June time again? I am planning on attending work permitting.
On Corepath Vs BIO.
My take is that Corepath are still responsible for the testing etc etc. But they was never paying for it. An accredited lab is needed as part of the process to test the entire spectrum of kit needed that will make up the approved FDA marked test.
BIO are paying for the facilitation of this and then marketing it.
The two trades must have been a transfer of some sort. They had no impact in either direction.
AS has not found a US Co to partner with, on acceptable terms to what he proposed. Hence Bill was clever enough to see the opportunity to try and set up a US Co and discuss the opportunity with his so called sophisticated HNWI, who he is asking to fund the next stages of developing the lab devloped test for US market. Fair enough Bill. Wise man.
What I find incredible is AS responding to a question about a test for UK market with the first country mentioned being China.
How can two £52K trades today go through at 1.80p when I could not even sell £10K the whole day.
Must be brokers, or else they were buys. But I tried a £7K buy after and Barclays would not allow it.
I predict that AS will avoid Investor Meet platform in future. He cannot avoid AGM. So I will be attending, as I hope you can Neil. We want the same outcome. An approved test ASAP
Tech think Widdy needed the rest
Bloviate - good word that
I don't know if you realise OAPk that you derided Widglide so much, you've turned into him by association! ;o)
I'm still retaining a healthy skepticism here. They do talk a good game. We'll see.